2,520
Views
0
CrossRef citations to date
0
Altmetric
Systematic Review

A review of caregiver costs included in cost-of-illness studies

ORCID Icon, , &
Pages 1051-1060 | Received 25 Feb 2022, Accepted 17 May 2022, Published online: 02 Jun 2022

References

  • Mattingly IITJ, Slejko JF, Perfetto EM, et al. What matters most for treatment decisions in hepatitis C: effectiveness, costs, and altruism. Patient. 2019;12:631–638.
  • dosReis S, Butler B, Caicedo J, et al. Stakeholder-engaged derivation of patient-informed value elements. Patient. 2020;13:611–621.
  • Garrison LP, Pauly MV, Willke RJ, et al. An overview of value, perspective, and decision context—A health economics approach: an ISPOR special task force report [2]. Value Heal. 2018;21:124–130.
  • Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS)–explanation and elaboration: a report of the ISPOR health economic evaluations publication guidelines task force. Value Heal. 2013;16:231–250.
  • Sanders GD, Neumann PJ, Basu A, et al. Recommendations for Conduct, methodological practices, and reporting of cost-effectiveness analyses. J Am Med Assoc. 2016;316:1093–1103.
  • Kim DD, Silver MC, Kunst N, et al. Perspective and costing in cost-effectiveness analysis, 1974–2018.Pharmacoeconomics.2020;38:1135–1145.
  • Lin PJ, D’Cruz B, Leech AA, et al. Family and caregiver spillover effects in cost-utility analyses of Alzheimer’s disease interventions. Pharmacoeconomics. 2019;37:597–608
  • Lavelle TA, D’Cruz BN, Mohit B, et al. Family spillover effects in pediatric cost-utility analyses. Appl Health Econ Health Policy. 2019;17:163–174**Authors. DOI:10.1007/s40258-018-0436-0.
  • Krol M, Papenburg J, van Exel J. Does including informal care in economic evaluations matter? A systematic review of inclusion and impact of informal care in cost-effectiveness studies. Pharmacoeconomics. 2015;33:123–135.
  • National Academies of Sciences Engineering and Medicine. Families Caring for an Aging America. Washington (DC): The National Academies Press; 2016.
  • Mattingly TJ, Wolff JL. Caregiver economics: a framework for estimating the value of the American jobs plan for a caring infrastructure. J Am Geriatr Soc. 2021;69:2370–3.
  • The White House. Fact sheet: the American jobs plan [Internet]. 2021 [cited 2021 Apr 2]. Available from: https://www.whitehouse.gov/briefing-room/statements-releases/2021/03/31/fact-sheet-the-american-jobs-plan/
  • Beauregard LK, Miller EA. Why do states pursue medicaid home care opportunities ? Explaining state adoption of the patient protection and affordable care act’s home and community-based services initiatives Russell Sage found. J Soc Sci. 2020;6:154–178.
  • Centers for Medicare & Medicaid Services. Home & community based services authorities. 2021
  • Hoefman RJ, van Exel J, Brouwer WBF. The monetary value of informal care: obtaining pure time valuations using a discrete choice experiment. Pharmacoecon. 2019;37:531–540.
  • Akobundu E, Ju J, Blatt L, et al. Cost-of-illness studies: a review of current methods. Pharmacoecon. 2006;24:869–890.
  • Onukwugha E, McRae J, Kravetz A, et al. Cost-of-illness studies: an updated review of current methods. Pharmacoecon. 2015;34:43–58
  • Kymes S. “Can we declare victory and move on?” The case against funding burden-of-disease studies. Pharmacoecon. 2014;32:1153–1155.
  • Larg A, Moss JR. Cost-of-illness studies: a guide to critical evaluation. Pharmacoecon. 2011;29:653–671.
  • Mattingly IITJ, Love BL, Khokhar B. Real world cost-of-illness evidence in hepatitis C virus: a systematic review. Pharmacoecon. 2020;38:927–939.
  • Grosse SD, Pike J, Soelaeman R, et al. Quantifying family spillover effects in economic evaluations: measurement and valuation of informal care time. Pharmacoecon. 2019;37:461–473.
  • Coe NB, Skira MM, Larson EB. A comprehensive measure of the costs of caring for a parent: differences according to functional status. J Am Geriatr Soc. 2018;66:2003–2008.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. PLoS Med. 2009;6:e1000097.
  • Covidence systematic review software. [Internet] Melbourne Australia: Veritas Health Innovation; Available from: www.covidence.org
  • Berndt ER, Cutler DM, Frank RG, et al. Price indexes for medical care goods and services: an overview of measurement issues. In: Cutler DM, Berndt ER, editors. Medical Care Output Product. Chicago, IL: University of Chicago Press; 2007. p. 141–200.
  • U.S. Bureau of Labor Statistics. Archived Consumer Price Index Supplemental Files [Internet]. 2021 [cited 2021 Aug 1]. Available from: https://www.bls.gov/cpi/tables/supplemental-files/home.htm
  • Turner HC, Lauer JA, Tran BX, et al. Adjusting for inflation and currency changes within health economic studies. Value Heal. 2019;22:1026–1032.
  • OANDA Corporation. Currency Converter [Internet]. 2021 [cited 2021 Oct 1]. Available from: https://www1.oanda.com/currency/converter/
  • Oliva-Moreno J, Peña-Longobardo LM, García-Mochón L, et al. The economic value of time of informal care and its determinants (The cuidarse study). PLoS One. 2019;14:1–16.
  • Schofield D, Zeppel MJB, Tanton R, et al. Informal caring for back pain: overlooked costs of back pain and projections to 2030. Pain. 2020;161:1012–1018.
  • Wolff N, Perlick DA, Kaczynski R, et al. Modeling costs and burden of informal caregiving for persons with bipolar disorder. J Ment Health Policy Econ. 2006;9:99–110.
  • Chan ATC, Jacobs P, Yeo W, et al. The cost of palliative care for hepatocellular carcinoma in Hong Kong. Pharmacoeconomics. 2001;19:947–953.
  • Hayman JA, Langa KM, Kabeto MU, et al. Estimating the cost of informal caregiving for elderly patients with cancer. J Clin Oncol. 2001;19:3219–3225.
  • Ortega-Ortega M, Montero-Granados R, Jiménez-Aguilera JDD. Differences in the economic valuation and determining factors of informal care over time: the case of blood cancer. Gac Sanit. 2018;32:411.
  • Sorensen SV, Goh JW, Pan F, et al. Incidence-based cost-of-illness model for metastatic breast cancer in the United States. Int J Technol Assess Health Care. 2012;28:12–21.
  • Wan Y, Gao X, Mehta S, et al. Indirect costs associated with metastatic breast cancer. J Med Econ. 2013;16:1169–1178.
  • Yu M, Guerriere DN, Coyte PC. Societal costs of home and hospital end-of-life care for palliative care patients in Ontario, Canada. Heal Soc Care Community. 2015;23:605–618. DOI:10.1111/hsc.12170.
  • Dunbar SB, Khavjou OA, Bakas T, et al. Projected costs of informal caregiving for cardiovascular disease: 2015 to 2035: a policy statement from the American heart association. Circulation. 2018;137:e558–e577.
  • Schofield D, Shrestha RN, Zeppel MJB, et al. Economic costs of informal care for people with chronic diseases in the community: lost income, extra welfare payments, and reduced taxes in Australia in 2015–2030. Heal Soc Care Community. 2019;27:493–501.
  • Turchetti G, Bellelli S, Amato M, et al. The social cost of chronic kidney disease in Italy. Eur J Heal Econ. 2017;18:847–858.
  • Peña-Longobardo LM, Oliva-Moreno J, Hidalgo-Vega Á, et al. Economic valuation and determinants of informal care to disabled people with chronic obstructive pulmonary disease (COPD) utilization, expenditure, economics and financing systems. BMC Health Serv Res. 2015;15:1–8.
  • Butler A, Gallagher D, Gillespie P, et al. Frailty: a costly phenomenon in caring for elders with cognitive impairment. Int J Geriatr Psychiatry. 2016;31:161–168.
  • Chong MS, Tan WS, Chan M, et al. Cost of informal care for community-dwelling mild-moderate dementia patients in a developed Southeast Asian country. Int Psychogeriatrics. 2013;25:1475–1483.
  • Costa N, Wübker A, De Mauléon A, et al. Costs of care of agitation associated with dementia in 8 European countries: results from the right time place care study. J Am Med Dir Assoc. 2018;19:95.e1–95.e10.
  • Darbà J, Kaskens L. Relationship between patient dependence and direct medical-, social-, indirect-, and informal-care costs in Spain. Clin Outcomes Res. 2015;7:387–395. DOI:10.2147/CEOR.S81045.
  • Ferretti C, Sarti FM, Nitrini R, et al. An assessment of direct and indirect costs of dementia in Brazil. PLoS One. 2018;13:e0193209.
  • Gillespie P, O’Shea E, Cullinan J, et al. The effects of dependence and function on costs of care for AlzheimerAlzheimer’s disease and mild cognitive impairment in Ireland. Int J Geriatr Psychiatry. 2013;28(3):256–264.
  • Holmerová I, Hort J, Rusina R, et al. Costs of dementia in the Czech Republic. Eur J Heal Econ. 2017;18(8):979–986.
  • Jutkowitz E, Kane RL, Gaugler JE, et al. Societal and family lifetime cost of dementia: implications for policy. J Am Geriatr Soc. 2017;65:2169–2175.
  • Kolanowski AM, Fick D, Waller JL, et al. Spouses of persons with dementia: their healthcare problems, utilization, and costs. Res Nurs Heal. 2004;27:296–306.
  • Peña-Longobardo LM, Oliva-Moreno J. Economic valuation and determinants of informal care to people with Alzheimer’s disease. Eur J Heal Econ. 2015;16:507–515.
  • Schwarzkopf L, Menn P, Kunz S, et al. Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage. Value Heal. 2011;14:827–835.
  • Sicras A, Rejas J, Arco S, et al. Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer’s dementia in a population setting. Dement Geriatr Cogn Disord. 2005;19:305–315.
  • Suh GH, Knapp M, Kang CJ. The economic costs of dementia in Korea, 2002. Int J Geriatr Psychiatry. 2006;21:722–728.
  • Vandepitte S, Van Wilder L, Putman K, et al. Factors associated with costs of care in community-dwelling persons with dementia from a third party payer and societal perspective: a cross-sectional study. BMC Geriatr. 2020;20:1–13.
  • Walsh S, Pertl M, Gillespie P, et al. Factors influencing the cost of care and admission to long-term care for people with dementia in Ireland. Aging Ment Heal. 2021;25:512–520.
  • Xu J, Wang J, Wimo A, et al. The economic burden of dementia in China, 1990-2030: implications for health policy. Bull World Health Organ. 2017;95:18–26.
  • Bermudez-Tamayo C, Besançon S, Johri M, et al. Direct and indirect costs of diabetes mellitus in Mali: a case-control study. PLoS One. 2017;12:1–15.
  • Chatterjee S, Riewpaiboon A, Piyauthakit P, et al. Cost of informal care for diabetic patients in Thailand. Prim Care Diabetes. 2011;5:109–115.
  • Cho H, Oh SH, Lee H, et al. The incremental economic burden of heart failure: a population-based investigation from South Korea. PLoS One. 2018;13:1–13.
  • Joo H, Fang J, Losby JL, et al. Cost of informal caregiving for patients with heart failure. Am Heart J. 2015;169:142–148.e2.
  • Zhou ZY, Koerper MA, Johnson KA, et al. Burden of illness: direct and indirect costs among persons with hemophilia A in the United States. J Med Econ. 2015;18:457–465.
  • Andersson A, Levin LÅ, Emtinger BG. The economic burden of informal care. Int J Technol Assess Health Care. 2002;18:46–54.
  • Tomita S, Hoshino E, Kamiya K, et al. Direct and indirect costs of home healthcare in Japan: a cross-sectional study. Heal Soc Care Community. 2020;28:1109–1117.
  • Kahn SA, Lin CW, Ozbay B, et al. Indirect costs and family burden of pediatric Crohn’s disease in the United States. Inflamm Bowel Dis. 2017;23:2089–2096.
  • Shannon CN, Simon TD, Reed GT, et al. The economic impact of ventriculoperitoneal shunt failure: clinical article. J Neurosurg Pediatr PED. 2011;8:593–599.
  • Schofield D, Zeppel MJB, Tanton R, et al. Intellectual disability and autism: socioeconomic impacts of informal caring, projected to 2030. Br J Psychiatry. 2019;215:654–660.
  • Diminic S, Lee YY, Hielscher E, et al. Quantifying the size of the informal care sector for Australian adults with mental illness: caring hours and replacement cost. Soc Psychiatry Psychiatr Epidemiol. 2021;56:387–400.
  • Carney P, O’Boyle D, Larkin A, et al. Societal costs of multiple sclerosis in Ireland. J Med Econ. 2018;21:425–437.
  • Schreiber-Katz O, Klug C, Thiele S, et al. Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany. Orphanet J Rare Dis. 2014;9:210.
  • Rafferty ER, Schurer JM, Arndt MB, et al. Pediatric cryptosporidiosis: an evaluation of health care and societal costs in Peru, Bangladesh and Kenya. PLoS One. 2017;12:1–16.
  • Burke RM, Smith ER, Dahl RM, et al. The economic burden of pediatric gastroenteritis to Bolivian families: a cross-sectional study of correlates of catastrophic cost and overall cost burden. BMC Public Health. 2014;14:642. DOI:10.1186/1471-2458-14-642.
  • Brodszky V, Tamási B, Hajdu K, et al. Disease burden of patients with pemphigus from a societal perspective. Expert Rev Pharmacoecon Outcomes Res. 2021;21:77–86.
  • Tilford JM, Grosse SD, Goodman AC, et al. Labor market productivity costs for caregivers of children with spina bifida: a population-based analysis. Med Decis Mak. 2009;29:23–32.
  • Brown DL, Boden-Albala B, Langa KM, et al. Projected costs of ischemic stroke in the United States. Neurology. 2006;67:1390–1395.
  • Riewpaiboon A, Riewpaiboon W, Ponsoongnern K, et al. Economic valuation of informal care in Asia: a case study of care for disabled stroke survivors in Thailand. Soc Sci Med. 2009;69:648–653.
  • Youman P, Wilson K, Harraf F, et al. The economic burden of stroke in the United Kingdom. Pharmacoeconomics. 2003;21:43–50.
  • Van Den Berg B, Brouwer W, Van Exel J, et al. Economic valuation of informal care: lessons from the application of the opportunity costs and proxy good methods. Soc Sci Med. 2006;62:835–845.
  • Thompson HJ, Weir S, Rivara FP, et al. Utilization and costs of health care after geriatric traumatic brain injury. J Neurotrauma. 2012;29:1864–1871.
  • Siegel JE, Weinstein MC, Russell LB, et al. Recommendations for reporting cost-effectiveness analyses. JAMA. 1996;276:1339–1341.
  • Krol M, Brouwer W. How to estimate productivity costs in economic evaluations. Pharmacoeconomics. 2014;32:335–344.
  • Schulz R, Beach SR. Caregiving as a risk factor for mortality: the caregiver health effects study. J Am Med Assoc. 1999;282:2215–2219.
  • Roth DL, Fredman L, Haley WE. Informal caregiving and its impact on health: a reappraisal from population-based studies. Gerontologist. 2015;55:309–319.